转移性肉瘤中断系统治疗 (药物假期):这是安全的吗?
Alessandra Maleddu1, Cole Wayant2
1Department of Medicine, University of Colorado Anschutz Medical Campus, 1665 Aurora Ct, MS F704, Room 5328, Aurora, CO, 80045, USA. alessandra.maleddu@cuanschutz.edu.
Current treatment options in oncology
|June 27, 2025
概括
转移性肉瘤的治疗具有挑战性. 本综述探讨了药物假期,以提高生活质量,同时保持肉瘤患者的整体存活率.
科学领域:
- 在瘤学瘤学.
- 医学瘤学 医学瘤学
- 肉瘤研究研究 肉瘤研究
背景情况:
- 瘤是一种罕见的,具有攻击性的介质瘤,对转移性疾病的治疗选择有限.
- 目前用于转移性肉瘤的化疗方案是有毒的,并提供糟糕的结果.
- 需要新的策略来平衡疾病控制和患者的生活质量.
研究的目的:
- 审查关于药物假期在肉瘤管理中的文献.
- 提供关于计划治疗中断的作用和可行性的指导.
- 评估治疗假期对整体生存率和生活质量的影响.
主要方法:
- 对转移性肉瘤中药假期研究的文献综述.
- 对治疗疗效和毒性数据的分析.
- 对患者报告结果和整体存活率的影响评估.
主要成果:
- 药物假期可以改善转移性肉瘤患者的生活质量.
- 治疗中断对整体存活时间的影响仍然不完全理解.
- 计划治疗假期的最佳持续时间和可行性需要进一步调查.
结论:
- 药物假期代表了提高转移性肉瘤患者生活质量的潜在策略.
- 进一步的研究至关重要,以确定治疗中断的最佳使用,而不会影响生存.
- 临床医生需要更新的指导来管理转移性肉瘤,重点是息治疗和生活质量.
相关概念视频
Renal Failure: Dose Adjustments
166
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
166
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K


